Home – PTX Therapeutics2018-08-30T23:13:24+00:00

Novel cancer therapies targeting key cancer pathways

READ MORE
Prescient Therapeutics PTX

We are a clinical stage oncology company developing novel drugs
that show great promise as potential new therapies to treat a range of cancers.

prescient therapeutics

OUR COMPANY

Prescient Therapeutics’ novel compounds inhibit key tumor survival pathways, inhibiting cancer growth and overcoming resistance to prior therapies.

Digital Brochure

Two Page Fact Sheet

prescient therapeutics

OUR SCIENCE

Our technologies emanate from renowned institutions Yale University and the Moffitt Cancer Center and are backed by a myriad of peer review publications.

prescient therapeutics

LATEST NEWS

15/01/2019Receipt of R&D Tax RebatePDF
19/12/2018Change of Director's Interest NoticePDF
19/12/2018Appendix 3BPDF
10/12/2018Interim Durability Analysis of PTX-200 Breast Cancer StudyPDF
20/11/2018Results of Annual General MeetingPDF
20/11/2018AGM PresentationPDF